Skin Diseases, Papulosquamous  >>  prezalumab (AMG 557)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
prezalumab (AMG 557) / Amgen, AstraZeneca
NCT01493518: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis

Terminated
1
6
US
AMG 557 or PLACEBO
Amgen
Psoriasis
05/13
06/13

Download Options